Stocks
Immunome (IMNM) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.00 | 0.55 | 4.87 | 1.40 | 3.10 | 2.48 | |||
| Changes by years, y/y, % | -13% | -72% | +783% | -71% | +121% | +6.2% | |||
Immunome. Debt/EBITDA
Immunome. Debt/EBITDA, changes, %
Immunome (IMNM) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.78 | 1.43 | 1.35 | 3.06 | 2.61 | 2.48 | ||
| Changes by years, y/y, % | -75% | -63% | -37% | +118% | +46% | |||
| Changes by quarters, q/q, % | +27% | -20% | -5% | +126% | -15% | |||
